comparemela.com
Home
Live Updates
Data Showed Promise With - Breaking News
Pages:
Data Showed Promise With News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Intercept Pharmaceuticals : EASL 2023 Podium Presentation of OCA-bezafibrate Combination Planned Interim Analysis
Results from a planned interim analysis of a randomized, double- blind, active-controlled trial evaluating the effects of obeticholic acid and bezafibrate on serum biomarkers in primary biliary cholangitis .
Czech republic
United states
Region flamande
Antonio civitarese
Frederik nevens
Lynda szczech
Alexandre louvet
Vaclav hejda
Cheng zou
University hospital in pilsen
University hospital of lille
Intercept pharmaceuticals inc
University hospital ku leuven
Primary biliary cholangitis
Data showed promise with
Obeticholic acid
vimarsana © 2020. All Rights Reserved.